Trial record 1 of 1 for:    NCT01262365
Previous Study | Return to List | Next Study

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (EMBODY 1)

This study is currently recruiting participants.
Verified March 2014 by UCB, Inc.
Sponsor:
Information provided by (Responsible Party):
UCB, Inc.
ClinicalTrials.gov Identifier:
NCT01262365
First received: December 14, 2010
Last updated: March 24, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)